Benjamin R Griffin1, Amanda Thomson2, Mark Yoder2, Isaiah Francis3, Sophia Ambruso4, Adam Bregman5, Michelle Feller2, Shannon Johnson-Bortolotto2, Christine King2, Deborah Bonnes2, Lisa Dufficy2, Chaorong Wu6, Anip Bansal5, Darlene Tad-Y7, Sarah Faubel4, Diana Jalal8. 1. Division of Renal Diseases and Hypertension/Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO. Electronic address: benjamin.griffin@cuanschutz.edu. 2. University of Colorado Health, Aurora, CO. 3. University of Colorado School of Public Health, Aurora, CO. 4. Division of Renal Diseases and Hypertension/Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO; Renal Section, Rocky Mountain Regional VA Medical Center, Aurora, CO. 5. Division of Renal Diseases and Hypertension/Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO. 6. Department of Biostatistics, Institute for Clinical and Translational Science, University of Iowa, Iowa City, IA. 7. Division of Hospital Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO. 8. Division of Nephrology/Department of Medicine, University of Iowa, Iowa City, IA.
Abstract
RATIONALE & OBJECTIVE: Clinical practice guidelines recommend delivering a continuous renal replacement therapy (CRRT) dose of 20 to 25mL/kg/h. However, practice patterns nationwide are highly variable; this inconsistent prescribing may lead to errors in medication dosing and increase rates of electrolyte and acid-base abnormalities. We describe an initiative to standardize CRRT practice patterns and reduce dosing variability. STUDY DESIGN: Quality improvement study. SETTING & PARTICIPANTS: Adult patients treated with CRRT at the University of Colorado Hospital between January 2016 and October 2017. QUALITY IMPROVEMENT ACTIVITIES: An assessment of the magnitude of the variability in CRRT dosing and the following specific interventions were implemented during the course of 1 year: (1) modification of the electronic medical record (EMR) to include calculated average 24-hour dose in real time, (2) modification of the CRRT procedure note to include comments on dosing, (3) modification of the CRRT order set to display calculations, and (4) yearly educational sessions for renal fellows outlining CRRT-specific dosing targets. OUTCOMES: The primary outcome was weekly percentage of CRRT treatments with an average delivered daily dose of 20 to 25mL/kg/h. Process and balancing outcomes included CRRT flowsheet accuracy, documentation of rates of delivered dose, and nursing satisfaction. ANALYTICAL APPROACH: Rates of weekly CRRT dosing in compliance with national guidelines were determined and used to create run charts showing compliance rates before and after the quality improvement interventions. RESULTS: Among 837 treatments before the intervention, 279 (33%) daily CRRT sessions achieved an average dose of 20 to 25mL/kg/h. Following implementation of interventions, 631 of 952 (66%) treatments achieved this goal. Week-to-week variation in dosing was significantly reduced. LIMITATIONS: A single-center study generating data that may not be generalizable to institutions with different CRRT nursing models or different EMR systems. CONCLUSIONS: Changes to the EMR and documentation templates and education of CRRT providers about dosing were associated with doubling of the rate of appropriate CRRT dosing and reduction in dosing variability.
RATIONALE & OBJECTIVE: Clinical practice guidelines recommend delivering a continuous renal replacement therapy (CRRT) dose of 20 to 25mL/kg/h. However, practice patterns nationwide are highly variable; this inconsistent prescribing may lead to errors in medication dosing and increase rates of electrolyte and acid-base abnormalities. We describe an initiative to standardize CRRT practice patterns and reduce dosing variability. STUDY DESIGN: Quality improvement study. SETTING & PARTICIPANTS: Adult patients treated with CRRT at the University of Colorado Hospital between January 2016 and October 2017. QUALITY IMPROVEMENT ACTIVITIES: An assessment of the magnitude of the variability in CRRT dosing and the following specific interventions were implemented during the course of 1 year: (1) modification of the electronic medical record (EMR) to include calculated average 24-hour dose in real time, (2) modification of the CRRT procedure note to include comments on dosing, (3) modification of the CRRT order set to display calculations, and (4) yearly educational sessions for renal fellows outlining CRRT-specific dosing targets. OUTCOMES: The primary outcome was weekly percentage of CRRT treatments with an average delivered daily dose of 20 to 25mL/kg/h. Process and balancing outcomes included CRRT flowsheet accuracy, documentation of rates of delivered dose, and nursing satisfaction. ANALYTICAL APPROACH: Rates of weekly CRRT dosing in compliance with national guidelines were determined and used to create run charts showing compliance rates before and after the quality improvement interventions. RESULTS: Among 837 treatments before the intervention, 279 (33%) daily CRRT sessions achieved an average dose of 20 to 25mL/kg/h. Following implementation of interventions, 631 of 952 (66%) treatments achieved this goal. Week-to-week variation in dosing was significantly reduced. LIMITATIONS: A single-center study generating data that may not be generalizable to institutions with different CRRT nursing models or different EMR systems. CONCLUSIONS: Changes to the EMR and documentation templates and education of CRRT providers about dosing were associated with doubling of the rate of appropriate CRRT dosing and reduction in dosing variability.
Authors: D W Bates; L Su; D T Yu; G M Chertow; D L Seger; D R Gomes; E J Dasbach; R Platt Journal: Clin Infect Dis Date: 2001-02-21 Impact factor: 9.079
Authors: Rinaldo Bellomo; Alan Cass; Louise Cole; Simon Finfer; Martin Gallagher; Serigne Lo; Colin McArthur; Shay McGuinness; John Myburgh; Robyn Norton; Carlos Scheinkestel; Steve Su Journal: N Engl J Med Date: 2009-10-22 Impact factor: 91.245
Authors: Damien du Cheyron; Bruno Bouchet; Jean-Jacques Parienti; Michel Ramakers; Pierre Charbonneau Journal: Intensive Care Med Date: 2005-10-22 Impact factor: 17.440
Authors: Jay L Koyner; Jorge Cerdá; Stuart L Goldstein; Bertrand L Jaber; Kathleen D Liu; Judy A Shea; Sarah Faubel Journal: Am J Kidney Dis Date: 2014-05-09 Impact factor: 8.860
Authors: Paul M Palevsky; Jane Hongyuan Zhang; Theresa Z O'Connor; Glenn M Chertow; Susan T Crowley; Devasmita Choudhury; Kevin Finkel; John A Kellum; Emil Paganini; Roland M H Schein; Mark W Smith; Kathleen M Swanson; B Taylor Thompson; Anitha Vijayan; Suzanne Watnick; Robert A Star; Peter Peduzzi Journal: N Engl J Med Date: 2008-05-20 Impact factor: 91.245
Authors: Makayla Cordoza; Kristen Rachinski; Kristin Nathan; Elisa B Crain; Diane Braxmeyer; Sarah Gore; Stephanie D Dubuc; Joel Wright Journal: J Nurs Care Qual Date: 2021 Oct-Dec 01 Impact factor: 1.597
Authors: Benjamin R Griffin; Chaorong Wu; John C O'Horo; Sarah Faubel; Diana Jalal; Kianoush Kashani Journal: Crit Care Med Date: 2021-02-01 Impact factor: 7.598
Authors: Dawn Opgenorth; Ellen Reil; Vincent Lau; Nancy Fraser; Danny Zuege; Xiaoming Wang; Sean M Bagshaw; Oleksa Rewa Journal: BMJ Open Date: 2022-02-04 Impact factor: 2.692
Authors: Eloy F Ruiz; Victor M Ortiz-Soriano; Monica Talbott; Bryan A Klein; Melissa L Thompson Bastin; Kirby P Mayer; Emily B Price; Robert Dorfman; Brandi N Adams; Lisa Fryman; Javier A Neyra Journal: Sci Rep Date: 2020-11-26 Impact factor: 4.379